奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HALO 奥洛兹美医疗

休市中 05-02 16:00:00 EDT

61.19

+1.16

+1.93%

盘后61.19

+0.000.00%

19:49 EDT

最高62.08	最低60.63	成交量109.85万
今开61.10	昨收60.03	日振幅2.41%
总市值75.59亿	流通市值74.76亿	总股本1.24亿
成交额6,729万	换手率0.90%	流通股本1.22亿
市净率20.78	ROE198.42%	每股收益3.43
52周最高66.00	52周最低39.79	市盈率17.84
股息0.00	股息收益率0.00	ROA18.16%

北京优虎网络科技有限公司

{"stockData":{"symbol":"HALO","market":"US","secType":"STK","nameCN":"奥洛兹美医疗","latestPrice":61.19,"timestamp":1746216000000,"preClose":60.03,"halted":0,"volume":1098491,"hourTrading":{"tag":"盘后","latestPrice":61.19,"preClose":61.19,"latestTime":"19:49 EDT","volume":28713,"amount":1756945.34,"timestamp":1746229758668},"delay":0,"floatShares":122174493,"shares":123533310,"eps":3.43,"marketStatus":"休市中","change":1.16,"latestTime":"05-02 16:00:00 EDT","open":61.1,"high":62.075,"low":60.63,"amount":67292921.53522,"amplitude":0.024071,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.43,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1099285200000,"exchange":"NASDAQ","adjPreClose":60.03,"preHourTrading":{"tag":"盘前","latestPrice":60.11,"preClose":60.03,"latestTime":"09:26 EDT","volume":794,"amount":48300.375358000005,"timestamp":1746192412698},"postHourTrading":{"tag":"盘后","latestPrice":61.19,"preClose":61.19,"latestTime":"19:49 EDT","volume":28713,"amount":1756945.34,"timestamp":1746229758668},"volumeRatio":0.9923728049052087,"impliedVol":0.4795,"impliedVolPercentile":0.804},"requestUrl":"/m/hq/s/HALO/tweets","defaultTab":"tweets","newsList":[{"id":"2529333098","title":"小摩：维持Halozyme Therapeutics(HALO.US)评级，由中性调整至中性评级, 目标价由55.00美元调整至58.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529333098","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529333098?lang=zh_cn&edition=full","pubTime":"2025-04-22 01:14","pubTimestamp":1745255699,"startTime":"0","endTime":"0","summary":"小摩：维持Halozyme Therapeutics(HALO.US)评级，由中性调整至中性评级, 目标价由55.00美元调整至58.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22011449732410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HALO","LENZ"],"gpt_icon":0},{"id":"2527242478","title":"奥洛兹美医疗盘中异动 早盘股价大跌5.01%报58.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527242478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527242478?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:23","pubTimestamp":1744813437,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时23分，奥洛兹美医疗股票出现异动，股价急速跳水5.01%。截至发稿，该股报58.21美元/股，成交量20.2885万股，换手率0.16%，振幅4.89%。最近的财报数据显示，该股实现营业收入10.15亿美元，净利润4.44亿美元，每股收益3.50美元，毛利7.85亿美元，市盈率17.00倍。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为1.42%。奥洛兹美医疗公司简介：Halozyme Therapeutics Inc 是一家专注于开发和商业化新型肿瘤疗法的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416222358973a0b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416222358973a0b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","HALO"],"gpt_icon":0},{"id":"2517912810","title":"传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912810","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517912810?lang=zh_cn&edition=full","pubTime":"2025-03-05 21:41","pubTimestamp":1741182111,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据报道，奥洛兹美医疗 与默沙东之间正在酝酿一场新的专利纠纷，争议的焦点是抗癌重磅药物Keytruda的注射版。知情人士透露，奥洛兹美医疗认为默沙东侵犯了其专利，应该签订许可协议才能销售注射用Keytruda。Keytruda几乎贡献了默沙东一半的总营收。默沙东去年表示，其注射版Keytruda在关键的3期试验中达到了主要目标。据报道，奥洛兹美医疗将在周三的投资者活动上讨论注射版Keytruda专利问题。截至发稿，默沙东盘前跌0.54%，奥洛兹美医疗涨0.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1917777945.USD","LU1066053197.SGD","LU0965509010.AUD","LU1989772840.SGD","BK4534","LU1162221912.USD","LU1066051498.USD","LU1934455277.USD","IE00BSNM7G36.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU1934455194.USD","LU2106854487.HKD","LU0053671581.USD","BK4139","IE00B1BXHZ80.USD","LU1116320737.USD","LU0965509101.SGD","IE00BBT3K403.USD","LU1066051811.HKD","LU1989772923.USD","SG9999002224.SGD","LU1093756325.SGD","LU1585245621.USD","LU1066051225.USD","LU1093756168.USD","LU1291159041.SGD","LU1035773651.USD","LU0265550359.USD","SG9999013999.USD","SG9999015358.SGD","LU0238689110.USD","IE0002141913.USD","LU2023250504.SGD","HALO","MRK","LU1023059063.AUD","LU2023250843.SGD","LU1571399168.USD","LU0965509283.SGD","LU1699723380.USD","LU2089984988.USD","BK4007","SG9999014575.USD","LU1037948897.HKD","LU1974910355.USD","LU1983299246.USD","LU0203347892.USD","SG9999015341.SGD","SG9999002232.USD"],"gpt_icon":0},{"id":"2513292619","title":"奥洛兹美医疗2024财年实现净利润4.44亿美元，同比增加57.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513292619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513292619?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:00","pubTimestamp":1740153649,"startTime":"0","endTime":"0","summary":"2月22日，奥洛兹美医疗公布财报，公告显示公司2024财年净利润为4.44亿美元，同比增加57.45%；其中营业收入为10.15亿美元，同比增加22.44%，每股基本收益为3.50美元。从资产负债表来看，奥洛兹美医疗总负债18.00亿美元，其中短期债务7.05百万美元，资产负债比为1.21，流动比率为7.81。机构评级：截至2025年2月22日，当前有9家机构对奥洛兹美医疗目标价做出预测，其中目标均价为66.11美元，其中最低目标价为53.00美元，最高目标价为78.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000113abd7c32f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000113abd7c32f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HALO"],"gpt_icon":0},{"id":"2512395109","title":"HC Wainwright & Co.：维持Halozyme Therapeutics(HALO.US)评级，由买入调整至买入评级, 目标价由70.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512395109","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512395109?lang=zh_cn&edition=full","pubTime":"2025-02-19 20:24","pubTimestamp":1739967879,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Halozyme Therapeutics(HALO.US)评级，由买入调整至买入评级, 目标价由70.00美元调整至72.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19202448265683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HALO","LENZ"],"gpt_icon":0},{"id":"1128172062","title":"Halozyme Therapeutics 2024年第4季度调整后每股收益$1.26超预期$1.16，销售额$2.98亿超预期$2.88亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1128172062","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128172062?lang=zh_cn&edition=full","pubTime":"2025-02-19 05:21","pubTimestamp":1739913666,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics公布了季度财报，公司调整后每股收益为$1.26，高于分析师普遍预期的$1.16，上涨幅度达8.62%。与去年同期的每股收益$0.82相比，这一数字增长了53.66%。公司报告的本季度销售额为$2.98亿，超出分析师预期的$2.88亿，超出幅度为3.39%。较去年同期$2.30亿的销售额相比增加了29.54%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Halozyme Therapeutics 2024年第4季度调整后每股收益$1.26超预期$1.16，销售额$2.98亿超预期$2.88亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO"],"gpt_icon":0},{"id":"2502089026","title":"Piper Sandler：维持Halozyme Therapeutics(HALO.US)评级，由中性调整至中性评级, 目标价由52.00美元调整至53.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502089026","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502089026?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:41","pubTimestamp":1736530916,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Halozyme Therapeutics(HALO.US)评级，由中性调整至中性评级, 目标价由52.00美元调整至53.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11014147364867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","HALO"],"gpt_icon":0},{"id":"2501877380","title":"奥洛兹美医疗盘中异动 早盘急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501877380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501877380?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:32","pubTimestamp":1736346720,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时32分，奥洛兹美医疗股票出现波动，股价急速上涨6.06%。截至发稿，该股报54.29美元/股，成交量10.4409万股，换手率0.08%，振幅1.29%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.19%。奥洛兹美医疗公司简介：奥洛兹美医疗有限公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223201a21a52d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223201a21a52d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HALO","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2485261660","title":"奥洛兹美医疗盘中异动 快速上涨7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261660?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285874,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，奥洛兹美医疗股票出现异动，股价急速拉升7.00%。截至发稿，该股报48.90美元/股，成交量27.8024万股，换手率0.22%，振幅1.27%。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.37%。奥洛兹美医疗公司简介：奥洛兹美医疗有限公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。奥洛兹美专注于在医疗需求未得到满足的治疗领域开发其专利产品，重点是肿瘤学，并将其技术授权给生物制药公司合作开发产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223115a24e2023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223115a24e2023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","HALO"],"gpt_icon":0},{"id":"2484927939","title":"奥洛兹美医疗盘中异动 快速拉升5.05%报44.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927939?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:29","pubTimestamp":1732033781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时29分，奥洛兹美医疗股票出现波动，股价大幅拉升5.05%。截至发稿，该股报44.72美元/股，成交量140.066万股，换手率1.10%，振幅4.70%。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.87%。消息层面，截至00时29分，《奥洛兹美医疗拟以21亿美元现金收购Evotech》资讯为影响奥洛兹美医疗的重要信息。奥洛兹美医疗公司生产的自动注射设备可以更快地将大量药物送入患者体内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120002942abcf9df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120002942abcf9df7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","HALO"],"gpt_icon":0},{"id":"2484674966","title":"奥洛兹美医疗盘中异动 早盘大幅跳水5.13%报43.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674966?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:52","pubTimestamp":1731941535,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时52分，奥洛兹美医疗股票出现异动，股价快速下挫5.13%。截至发稿，该股报43.31美元/股，成交量40.1102万股，换手率0.32%，振幅4.85%。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.35%。消息层面，截至22时52分，《奥洛兹美医疗拟以21亿美元现金收购Evotech》资讯为影响奥洛兹美医疗的重要信息。奥洛兹美医疗公司生产的自动注射设备可以更快地将大量药物送入患者体内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822521598e43450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822521598e43450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","HALO","BK4139"],"gpt_icon":0},{"id":"2484305620","title":"金十数据整理：每日美股市场要闻速递（11月18日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2484305620","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484305620?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:34","pubTimestamp":1731936889,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["NVDS.UK","BK4592","LU0795875169.SGD","NVDL","SNVD.UK","NVDX","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1066051498.USD","LU2360106780.USD","BA","IE00BJJMRX11.SGD","LU2505996681.GBP","TSLA","EVO","2NVD.UK","NVDS","SG9999001424.SGD","LU2264538146.SGD","LU0957791311.USD","NVD","CAAS","LU1221951046.USD","LU2461242641.AUD","LU1778281490.HKD","LLY","LU0719512351.SGD","LU1852331112.SGD","NIU","IE00BJJMRZ35.SGD","BK4555","MCD","NVDD","NVD3.UK","HALO","BK4527","SMCI","IE00B1XK9C88.USD","LU2237443382.USD","LU1923623000.USD","NVDA","NVD2.UK","NVDY","LU0889566641.SGD","EH","LU2065169927.USD","3NVD.UK","JNJ","NVDU","SG9999018857.SGD"],"gpt_icon":0},{"id":"2484438346","title":"奥洛兹美医疗(HALO)拟收购Evotech(EVO) 涉资以21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484438346","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484438346?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:32","pubTimestamp":1731918744,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据媒体，奥洛兹美医疗(HALO)首席执行官海伦·托利(Helen Torley)称，公司计划以现金形式融资20亿欧元(合21亿美元)收购德国Evotec公司(EVO)。Torley在接受采访时表示：“我们有信心以全额现金交易的方式为这笔交易提供资金。不会动用股权。她表示：“由于我们承担了一些债务，我们强劲的现金流将能够在交易完成后迅速将我们的杠杆率降至两倍。”据悉，总部位于圣地亚哥的奥洛兹美医疗预计将以手头约6亿美元的现金和剩余的债务为部分收购提供资金。Torley补充说，该公司正与潜在银行贷款人敲定债务融资。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"282090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVO","BK4121","BK4139","HALO","LU0053671581.USD"],"gpt_icon":0},{"id":"2484131276","title":"奥洛兹美医疗拟以21亿美元现金收购Evotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2484131276","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484131276?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:01","pubTimestamp":1731913289,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据外媒报道，奥洛兹美医疗 首席执行官海伦·托利称，公司计划以现金形式融资20亿欧元收购德国Evotec公司。","market":"sh","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212155.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EVO","BK4139","LU0053671581.USD","BK4121","HALO"],"gpt_icon":1},{"id":"2483634273","title":"Halozyme(HALO)有意收购德国Evotec","url":"https://stock-news.laohu8.com/highlight/detail?id=2483634273","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483634273?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:47","pubTimestamp":1731664049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德国Evotec SE 引起了纳斯达克上市生物科技公司 Halozyme Therapeutics Inc. (HALO)的收购兴趣，这笔交易将使这家德国药物开发商的估值达到 20 亿欧元（21 亿美元）。公司已提交了一份不具约束力的收购要约，以每股 11 欧元的价格收购 Evotec。这比 Evotec 周四的收盘价高出约 27%。Halozyme 首席执行官 Helen Torley 在声明中表示，收购 Evotec 将使公司的增长延续到下一个十年甚至更远。她表示，“凭借规模的扩大、深厚的产品线和多样化的产品，我们将成为生物制药行业极具吸引力的战略合作伙伴。”","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/NDFiZjhjZDNhYWRlYWZlZWY0NGExMDE1Mzc1NDE5NjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NDFiZjhjZDNhYWRlYWZlZWY0NGExMDE1Mzc1NDE5NjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"282028","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2483633378","title":"奥洛兹美医疗盘中异动 股价大跌5.77%报55.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483633378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483633378?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:05","pubTimestamp":1731611114,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时05分，奥洛兹美医疗股票出现波动，股价大幅跳水5.77%。截至发稿，该股报55.23美元/股，成交量67.8007万股，换手率0.53%，振幅5.61%。最近的财报数据显示，该股实现营业收入2.90亿美元，净利润1.37亿美元，每股收益1.08美元，毛利2.23亿美元，市盈率18.82倍。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.98%。奥洛兹美医疗公司简介：奥洛兹美医疗有限公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111503051498e42b71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111503051498e42b71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HALO","LU0053671581.USD"],"gpt_icon":0},{"id":"2482848548","title":"奥洛兹美医疗2024财年第三财季实现净利润1.37亿美元，同比增加67.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482848548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482848548?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081634,"startTime":"0","endTime":"0","summary":"11月9日，奥洛兹美医疗公布财报，公告显示公司2024财年第三财季净利润为1.37亿美元，同比增加67.40%；其中营业收入为2.90亿美元，同比增加34.26%，每股基本收益为1.08美元。从资产负债表来看，奥洛兹美医疗总负债16.65亿美元，其中短期债务0.00美元，资产负债比为1.28，流动比率为10.34。机构评级：截至2024年11月9日，当前有10家机构对奥洛兹美医疗目标价做出预测，其中目标均价为62.60美元，其中最低目标价为50.00美元，最高目标价为75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000256a224f793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000256a224f793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HALO"],"gpt_icon":0},{"id":"1196868881","title":"异动解读 | 奥洛兹美医疗业绩超预期 上调全年指引 股价盘前大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1196868881","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196868881?lang=zh_cn&edition=full","pubTime":"2024-11-02 02:52","pubTimestamp":1730487158,"startTime":"0","endTime":"0","summary":"北京时间2024年11月1日盘前,奥洛兹美医疗(HALO,LENZ)股价大涨16.67%,收于58.01美元,引发市场广泛关注。\n\n公司此前公布的2024财年第三季度业绩显示,每股收益达到1.27美元,远超分析师预期的0.98美元。受业绩向好拉动,奥洛兹美还上调了全年收入预期,将原先的9.35亿到10.2亿美元上修至9.7亿至10.2亿美元。\n\n公司预计,2024年全年特许权使用费收入将同比增长23%至26%,达到5.5亿至5.65亿美元;产品销售额也有较大增长。因此公司进一步上调每股收益预期,由之前的3.65至4.05美元上修至4.00至4.20美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HALO"],"gpt_icon":0},{"id":"2480889530","title":"奥洛兹美医疗盘中异动 早盘快速拉升6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889530?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467953,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，奥洛兹美医疗股票出现异动，股价快速拉升6.92%。截至发稿，该股报54.07美元/股，成交量15.453万股，换手率0.12%，振幅6.12%。机构评级方面，在所有12家参与评级的机构中，58%的券商给予买入建议，42%的券商给予持有建议，无券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.06%。奥洛兹美医疗公司简介：奥洛兹美医疗有限公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121323395bdab0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121323395bdab0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","HALO","BK4139"],"gpt_icon":0},{"id":"1170238672","title":"异动解读 | 奥洛兹美医疗业绩超预期 上调全年指引 股价盘前飙升16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170238672","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170238672?lang=zh_cn&edition=full","pubTime":"2024-11-01 18:42","pubTimestamp":1730457741,"startTime":"0","endTime":"0","summary":"今日盘前,奥洛兹美医疗股价大涨16.67%,最新报收58.01美元,引发市场广泛关注。奥洛兹美公司公布了2024财年第三季度业绩,每股收益1.27美元远超分析师预期的0.98美元。该公司预计,全年特许权使用费收入将达到5.5亿至5.65亿美元,同比增长23%至26%,产品销售额也有较大增长。奥洛兹美医疗第三季度业绩和全年指引给市场带来很大的惊喜,公司估值也随之得到修复。该股今年迄今累计上涨36.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HALO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.halozyme.com","stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.029},{"period":"3month","weight":0.0803},{"period":"6month","weight":0.0707},{"period":"1year","weight":0.5367},{"period":"ytd","weight":0.2799}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Halozyme Therapeutics, Inc.是一家生物制药公司,成立于1998年。2007年11月，该公司重组并注册于特拉华州（以前注册于内华达州）。该公司致力于创新产品的开发和商业化。公司研究细胞外基质、细胞外区域,包括细胞迁移、信号和存活。多年来,该公司已经开发了独特的科学专业知识, 允许其追求侧重于环境发展的治疗办法。","yearOnYearQuotes":[{"month":1,"riseRate":0.47619,"avgChangeRate":-0.008587},{"month":2,"riseRate":0.619048,"avgChangeRate":0.02532},{"month":3,"riseRate":0.52381,"avgChangeRate":0.043178},{"month":4,"riseRate":0.590909,"avgChangeRate":-0.006442},{"month":5,"riseRate":0.545455,"avgChangeRate":0.008871},{"month":6,"riseRate":0.619048,"avgChangeRate":0.049232},{"month":7,"riseRate":0.619048,"avgChangeRate":0.029387},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.01627},{"month":9,"riseRate":0.333333,"avgChangeRate":0.021046},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.023867},{"month":11,"riseRate":0.619048,"avgChangeRate":0.06441},{"month":12,"riseRate":0.571429,"avgChangeRate":0.118344}],"exchange":"NASDAQ","name":"奥洛兹美医疗","nameEN":"Halozyme Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥洛兹美医疗(HALO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥洛兹美医疗,HALO,奥洛兹美医疗股票,奥洛兹美医疗股票老虎,奥洛兹美医疗股票老虎国际,奥洛兹美医疗行情,奥洛兹美医疗股票行情,奥洛兹美医疗股价,奥洛兹美医疗股市,奥洛兹美医疗股票价格,奥洛兹美医疗股票交易,奥洛兹美医疗股票购买,奥洛兹美医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥洛兹美医疗(HALO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}